The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A war weapon used in World War One went on to become a key component in treating blood cancer with chemotherapy ...

Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

The damage to these cells can cause potential side effects, like fatigue, vomiting and nausea, but it’s important to note ...

Spokane may be hundreds of miles from major academic medical centers, but its becoming a national leader in an advanced ...

As brain tumors grow, they must do one of two things: push against the brain or use finger-like extensions to invade and ...

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues.